Tech Company Financing Transactions
En Carta Diagnostics Funding Round
En Carta Diagnostics, based in Malakoff, scored $1.6 million from private investors.
Transaction Overview
Company Name
Announced On
5/22/2024
Transaction Type
Venture Equity
Amount
$1,600,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to develop a diagnostic kit, with the purpose of autonomously detecting Lyme disease within minutes and to implement its go-to-market strategy.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
4 Rue Emile Zola
Malakoff, 92240
France
Malakoff, 92240
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Located in the heart of Paris, born out of a passion for synthetic biology and a dream to break the barriers in equal healthcare access, En Carta employs its groundbreaking technology in a powerful and versatile diagnostics platform. We develop accurate, accessible, and affordable molecular diagnostics to be used by anyone, anywhere.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guillaume Horreard
Browse more venture capital transactions:
Prev: 5/22/2024: SOCRadar venture capital transaction
Next: 5/22/2024: Artemis venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs